Tag - COVID-19

Rewiring Precision Medicine: How AI Is Transforming Science and Business

Regeneron Enters into Asset Purchase Agreement to Acquire 23andMe® for $256 Million; Plans to Maintain Consumer Genetics Business and Advance Shared Goals of Improving Human Health and Wellness

AI model trained on de-identified data from 57 million people

A Look at Human Longevity & Life Expectancy

2024 in Review

2023: Ozempic, 2nd Biggest Bank Collapse, AlphaFold, FDA Approval of Gene Therapy and CRISPR Gene Editing,….

Velsera Is Building an Ecosystem that Accelerates the R&D Loop and Democratizes Omics Data to Propel the Next Era of Precision Medicine

2021, The Year of the Various SARS-CoV-2 Variants of Concern – from Alpha to Omicron

2021 – Precision Medicine linked with Genomic Medicine: A Work in Progress

Patient-Centric Rare Disease Genome Maps Join The Web

Bionano Genomics Acquiring BioDiscovery – The Perfect Alignment of the Stars

Color announces Series E financing, at a valuation of $4.6 billion, to accelerate expansion of accessible and equitable public health infrastructure

Scientific Integrity: A Coincidental Encounter

Illumina Acquires GRAIL to Accelerate Patient Access to Life-Saving Multi-Cancer Early-Detection Test

A Review of SARS-CoV-2 Variants

Element Biosciences Closes $276 Million Series C Financing to Democratize Access to Genomics

Copyright © 2026. enlighenbio LLC. All rights reserved.